SCHEMBL10869809

SCHEMBL10869809

c1ccc(-c2nc3c(N4CCSCC4)nc(N4CCNCC4)nc3nc2N2CCNCC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 5/20 0.49
PDE4B Q07343 5/20 0.49
PDE4C Q08493 5/20 0.49
PDE4D Q08499 5/20 0.49
ALDH1A1 P00352 4/20 0.48
HPGD P15428 2/20 0.48
CYP1A2 P05177 4/20 0.43
NPSR1 Q6W5P4 3/20 0.43
CYP2C9 P11712 3/20 0.43
CYP2C19 P33261 3/20 0.43
KMT2A Q03164 3/20 0.43
HIF1A Q16665 3/20 0.43
POLB P06746 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
KDM4E B2RXH2 1/20 0.43
S1PR2 O95136 1/20 0.43
LMNA P02545 1/20 0.43
CETP P11597 1/20 0.40
ATM Q13315 1/20 0.40
HTR2C P28335 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10870587 0.88 PDE4A (0.60) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL10873486 0.86 CASP1 (0.53) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL10869613 0.86 CASP1 (0.53) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL10870557 0.84 PDE4A (0.65) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL10869862 0.82 PDE4A (0.44) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL10869864 0.82 PDE4A (0.42) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL10869451 0.79 CASP1 (0.46) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL10708549 0.78 PDE4A (0.78) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL10869738 0.78 NPSR1 (0.44) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL10869789 0.77 PDE4A (0.66) PDE4APDE4BPDE4CPDE4DALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0185259-A2 Pteridines, process for their preparation, and their use as intermediates or as medicaments Dr. Karl Thomae GmbH (DE) 1986-06-25 EP disclosed